3D C-Vit model improves tumor grading accuracy in 340 pediatric brain tumor cases
New AI Tool Grades Pediatric Brain Tumors With 91% Accuracy
This retrospective cohort review evaluated a 3D C-Vit model against clinical and radiomics models in 340 pediatric brain tumor cases.
A new AI tool grades pediatric brain tumors with 91% accuracy, helping doctors plan treatment faster and more reliably.
Narrative Review Examines Stereotactic Radiotherapy Use in Cancer Patients With Brain Metastases
More Brain Mets? This Radiation Advance Changes Everything
This narrative review examines the role of stereotactic radiotherapy in cancer patients with brain metastases.
Every year, more cancer patients face a terrifying diagnosis: brain metastases.
Retrospective observational study evaluates systemic therapy surveillance in brain metastases patients
Observational study examines MRI surveillance patterns in patients with active brain metastases
This retrospective observational study abstract examines surveillance practices in 33 patients with active brain metastases treated with sys…
Doctors monitoring brain metastasis patients with new drugs found no difference in tumor growth or radiation needs whether they followed gui…
Non-randomized trial of neuromodulation prehabilitation for brain tumor language networks
Small study tests brain stimulation and language training before brain tumor surgery
This is a non-randomized controlled trial in 26 patients with operable brain tumors.
Brain stimulation and language training before surgery reduced overlap between stimulation targets and language areas in patients with opera…
Stereotactic radiation improves symptoms versus hippocampal-avoidance whole brain radiation in patients with 5 to 20 brain metastases
Targeted Brain Radiation Eases Symptoms More Than Full-Brain Treatment
This Phase 3 randomized clinical trial enrolled 196 patients with 5 to 20 brain metastases and no prior brain-directed radiation across four…
Targeted radiation for brain tumors preserves daily functioning and quality of life better than whole-brain treatment in cancer patients wit…
Review of SIMMA utility for paediatric tumour monitoring via cfDNA profiling and ecDNA detection
A Simple Blood Test May Catch Children's Cancer Relapse Months Early
This review evaluates the clinical utility of the SIMMA single-molecule sequencing approach for profiling circulating and cerebrospinal flui…
A single blood or spinal fluid draw can now map a child's tumor DNA at a level of detail that may warn doctors of relapse long before scans …
Review of non-invasive prehabilitation for neuro-oncology patients at Institut Guttmann in Barcelona
Brain Tumor Surgery Is Terrifying — What If You Could Prepare Your Mind First?
This primary trial review examines a non-invasive prehabilitation (PRH) program in 29 neuro-oncology patients at Institut Guttmann in Barcel…
A pre-surgery wellness program significantly reduced emotional distress and improved quality of life for adults facing brain tumor removal.
Neurosurgery patients with brain tumors show preoperative financial capacity deficits compared to healthy controls
Brain tumor surgery patients often struggle with financial tasks before and after the operation
This prospective observational study evaluated 21 patients with brain tumors and 21 age- and education-matched healthy controls.
Brain tumor surgery patients often struggle with financial tasks like reading bills, and many overestimate their ability to manage money.
First-line osimertinib shows high response rates in EGFR-mutated NSCLC with active brain metastases
Untreated Brain Metastases Respond Well to Osimertinib
This single-arm phase II trial evaluated first-line osimertinib in 100 patients with EGFR-mutated non-small cell lung cancer, including thos…
Osimertinib, a lung cancer drug, effectively treats untreated brain metastases, with an 81.8% response rate for measurable brain spots in a …
Systematic review finds variable MRI segmentation accuracy for pituitary adenomas and gland
Can AI Outline a Pea-Sized Brain Gland Better Than Humans?
A systematic review of 34 studies analyzed automatic and semi-automatic MRI segmentation methods for pituitary adenomas and the pituitary gl…
Artificial intelligence is getting good at tracing pituitary tumors on brain scans, but it still struggles with the tiny gland itself.
Elevated neutrophil-to-lymphocyte ratio predicts brain metastasis risk in lung cancer patients
Could a simple blood test help find who is most at risk for brain metastasis from lung cancer?
This systematic review and meta-analysis evaluated three immune inflammatory markers in 3,643 participants with lung cancer.
A simple blood test showing high inflammation markers can predict who is most likely to develop brain metastasis from lung cancer.
EMILIN-1 shows dual tumor-suppressive and promoting roles in brain tumor biology review
Review explores dual role of EMILIN-1 protein in brain tumor biology
A systematic review of experimental data describes EMILIN-1's complex role in nervous system tumors.
A protein called EMILIN-1 might slow brain tumors in some ways but could also change the immune response to help them grow faster.
Questions about Brain Metastasis
Can a high neutrophil-to-lymphocyte ratio predict if a lung cancer patient will develop brain metastasis?
Yes, a high neutrophil-to-lymphocyte ratio (NLR) is linked to a higher risk of developing brain metastasis in lung cancer patients, according to a meta-analysis and other studies.
Full answer →How well does osimertinib work for lung cancer patients who have active brain metastasis?
Osimertinib is effective for EGFR-mutated NSCLC patients with active brain metastases, with real-world data showing median progression-free survival of 12.4 months and intracranial responses, though resistance can develop.
Full answer →Is stereotactic radiotherapy an effective treatment option for patients with brain metastasis?
Yes, stereotactic radiotherapy is an effective treatment for brain metastases, offering high local control rates and preserving cognitive function.
Full answer →What are the microenvironment mechanisms that drive lung cancer brain metastasis?
Lung cancer brain metastasis is driven by tumor cells co-opting brain developmental pathways, secreting exosomal CEMIP and LCN2, and recruiting astrocytes and macrophages to create a supportive niche.
Full answer →What are the risks of brain metastasis in patients diagnosed with lung cancer?
Brain metastases are common in lung cancer, especially small cell (15% at diagnosis) and non-small cell types, with elevated neutrophil-to-lymphocyte ratio as a risk factor; targeted therapies like osimertinib show high intracranial response rates.
Full answer →